Immunotherapy
News and reporting on cancer immunotherapy.
PamGene, Alithea Genomics, Lausanne University get €1M for Pan-Cancer Blood Test
The Dutch-Swiss Mainline consortium plans to develop a multiomics model to guide immune checkpoint inhibitor therapy across a broad range of cancers.
FDA Approves Thermo Fisher HLA Typing Test as CDx for Immunocore Uveal Melanoma Therapy
The marketing authorization makes Thermo Fisher’s SeCore CDx HLA Sequencing System the first and so far only commercially available HLA typing companion diagnostic.
Navignostics Using Single-Cell Spatial Proteomics to Guide Oncology Treatment, Drug Development
Premium
The University of Zurich spinout is using Standard BioTools' Hyperion system for its analyses and recently raised CHF 7.5 million in seed funding.
Novigenix Raises $14M in First Closing of Series B
The Swiss company plans to use the funds for clinical validation of its NGS-based liquid biopsy, with a second Series B closing planned early next year.
The firm is working on more assays to help decide which cancer patients are suitable for immunotherapies and hopes to establish a US-based lab in 2023.